Satoko Takizawa Selected Research

CCR3 Receptors

6/2007	A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
4/2006	A novel, selective, and orally available antagonist for CC chemokine receptor 3.
1/2006	In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoko Takizawa Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 01/2011
5	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2016
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2019
3	Inflammation (Inflammations) 06/2007 - 01/2006
3	Asthma (Bronchial Asthma) 06/2007 - 01/2006
2	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 10/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2011
2	Sarcoma (Soft Tissue Sarcoma) 08/2021 - 01/2019
2	Esophageal Squamous Cell Carcinoma 02/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 02/2020 - 01/2011
2	Atopic Dermatitis (Atopic Eczema) 06/2007 - 01/2006
1	Autoimmune Hepatitis 01/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 08/2021
1	Osteosarcoma (Osteogenic Sarcoma) 08/2021
1	Liposarcoma 08/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Liver Diseases (Liver Disease) 02/2020
1	Disease Progression 02/2020
1	Chronic Hepatitis (Chronic Active Hepatitis) 02/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Lymphoma (Lymphomas) 12/2019
1	Brain Neoplasms (Brain Tumor) 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 12/2019
1	Glioma (Gliomas) 12/2019
1	Leiomyosarcoma 12/2019
1	Lymphatic Metastasis 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Stroke (Strokes) 01/2019
1	Breast Diseases (Breast Disease) 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Dementia (Dementias) 01/2019
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Crohn Disease (Crohn's Disease) 10/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2010
1	Allergic Rhinitis 06/2007
1	Rhinitis 04/2006
1	Hypersensitivity (Allergy) 01/2006

Drug/Important Bio-Agent (IBA)

26	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2011
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
3	CCR3 ReceptorsIBA 06/2007 - 01/2006
2	Circulating MicroRNAIBA 02/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 02/2010
1	Programmed Cell Death 1 ReceptorIBA 02/2020
1	NivolumabIBA 02/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	eribulin FDA Link 01/2019
1	AnthracyclinesIBA 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	taxaneIBA 01/2019
1	doramapimodIBA 10/2011
1	p38 Mitogen-Activated Protein KinasesIBA 10/2011
1	Alanine Transaminase (SGPT)IBA 10/2011
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 02/2010
1	Histamine (Histamine Dihydrochloride)FDA Link 06/2007
1	ChemokinesIBA 06/2007
1	Anti-Allergic Agents (Antiallergic Agents)IBA 06/2007
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 06/2007
1	N- (1- ((6- fluoro- 2- naphthyl)methyl)pyrrolidin- 3- yl)- 2- (1- ((6- methylpyridazin- 3- yl)carbonyl)piperidin- 4- ylidene)acetamideIBA 06/2007
1	CC ChemokinesIBA 04/2006
1	LigandsIBA 04/2006
1	Chemokine CCL24IBA 04/2006
1	Monocyte Chemoattractant ProteinsIBA 04/2006
1	Chemokine CCL26IBA 04/2006
1	N- (1- ((6- fluoro- 2- naphthyl)methyl)pyrrolidin- 3- yl)- 2- (1- ((3- methyl- 1- oxidopyridin- 2- yl)carbonyl)piperidin- 4- ylidene)acetamideIBA 01/2006
1	Chemokine CCL11IBA 01/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 12/2022 - 01/2020
1	Neoadjuvant Therapy 04/2024
1	Palliative Care (Palliative Therapy) 12/2022
1	Radiotherapy 01/2022
1	Adjuvant Chemotherapy 01/2020
1	Therapeutics 01/2019